DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-429 Cr | ₹-974 Cr | ₹-629 Cr | ₹-1,276 Cr | ₹-1,040 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DR REDDYS LABORATORIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹-429 Cr |
Mar2024 | ₹-974 Cr |
Mar2023 | ₹-629 Cr |
Mar2022 | ₹-1,276 Cr |
Mar2021 | ₹-1,040 Cr |
How is Deferred Tax Assets / Liabilities of DR REDDYS LABORATORIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹-429 Cr | Negative | |
Mar2024 | ₹-974 Cr | Negative | |
Mar2023 | ₹-629 Cr | Negative | |
Mar2022 | ₹-1,276 Cr | Negative | |
Mar2021 | ₹-1,040 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹101,787.8 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
MANKIND PHARMA | ₹105,753.0 Cr | 0.8% | 8.4% | 26.4% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -5.2% |
-5.7% |
-5.9% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses